Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Targeting NDUFS4 Disrupts Oxidative Phosphorylation and Induces Ferroptosis in Olaparib-Resistant Prostate Cancer.
Journal: Molecular cancer therapeutics
Published: September 24, 2025
Targeting NDUFS4 Disrupts Oxidative Phosphorylation and Induces Ferroptosis in Olaparib-Resistant Prostate Cancer.
Journal: Molecular cancer therapeutics
Published: September 24, 2025
IGFBP3-SphK1/S1P Signaling Axis Drives Enzalutamide Resistance in Advanced Prostate Cancer.
Journal: Molecular cancer therapeutics
Published: June 09, 2025
Steroid Sulfatase Regulates Metabolic Reprogramming in Advanced Prostate Cancer.
Journal: Cancers
Published: April 16, 2025
Correction: Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer.
Journal: Oncotarget
Published: October 01, 2024
PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer Cells.
Journal: Cancer research communications
Published: June 20, 2024
LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer Therapy.
Journal: Cancer research
Published: February 05, 2024
Therapeutic Resistance Models and Treatment Sequencing in Advanced Prostate Cancer.
Journal: Cancers
Published: October 13, 2023
IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer.
Journal: iScience
Published: August 15, 2023
Wntless expression promotes lineage plasticity and is associated with neuroendocrine prostate cancer.
Journal: American journal of clinical and experimental urology
Published: July 22, 2022
Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment.
Journal: Molecular cancer therapeutics
Published: March 28, 2022
Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes.
Journal: Communications medicine
Published: February 03, 2022
Last Updated: 09/26/2026